2013-08-01
The receptor binding domain of the new middle east respiratory syndrome coronavirus maps to a 231-residue region in the spike protein that efficiently elicits neutralizing antibodies
Publication
Publication
Journal of Virology , Volume 87 - Issue 16 p. 9379- 9383
The spike (S) protein of the recently emerged human Middle East respiratory syndromecoronavirus (MERS-CoV) mediates infection by binding to the cellular receptor dipeptidyl peptidase 4 (DPP4). Here we mapped the receptor binding domain in the S protein to a 231-amino-acid fragment (residues 358 to 588) by evaluating the interaction of spike truncation variants with receptor-expressing cells and soluble DPP4. Antibodies to this domain-mch less so those to the preceding N-terminal region-efficiently neutralize MERS-CoV infection.
Additional Metadata | |
---|---|
doi.org/10.1128/JVI.01277-13, hdl.handle.net/1765/64810 | |
Journal of Virology | |
, | |
Organisation | Department of Virology |
Mou, H., Raj, S., van Kuppeveld, F., Rottier, P., Haagmans, B., & Bosch, B. J. (2013). The receptor binding domain of the new middle east respiratory syndrome coronavirus maps to a 231-residue region in the spike protein that efficiently elicits neutralizing antibodies. Journal of Virology, 87(16), 9379–9383. doi:10.1128/JVI.01277-13 |